Clinical Trial Update: The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype [Phase 2]

View source ↗

Summary

Phase 2 trial update on using decitabine as induction therapy for acute myeloid leukemia with complex and/or monosomal karyotype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Complex Karyotype

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: The University of Hong Kong | Conditions: Acute Myeloid Leukemia, Complex Karyotype | Phase 2 | Status: UNKNOWN